Abstract
The main objective of this work was to evaluate the behavior of composite microparticles (microparticles containing nanoparticles) for parenteral delivery with a view to reducing the initial burst release of short half-lives peptides/proteins (using insulin as a model drug). These composite microparticles were prepared with hydrophobic and biodegradable polymers [Poly (ε-caprolactone), poly (lactic-co-glycolic) acid] by the double emulsion extraction technique. Particles were administered subcutaneously (1IU/kg of insulin) as a single dose to diabetic rats (streptozotocin-induced) and serum insulin levels were monitored. The results show a significant reduction of insulin release from composite microparticles both in vitro (around 19% after 15 min) and in vivo (around 582μU/mL) with a progressive and controlled release profile up to 24 h when compared to simple microparticles (without nanoparticles inside) and nanoparticles. These experiments demonstrate that a desirable insulin injection formulation with negligible burst effect in vivo has been developed. Such effect was attributed to the double polymer barrier that the drug has to diffuse through before reaching the external medium either in vitro or in vivo.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.